Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extension - Université de Versailles Saint-Quentin-en-Yvelines Access content directly
Journal Articles Seminars in Arthritis and Rheumatism Year : 2023

Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extension

Philippe Carron
  • Function : Author
Corine Gaillez
  • Function : Author
Philip G Conaghan
  • Function : Author
Esperanza Naredo
  • Function : Author
Alejandra López-Rdz
  • Function : Author
Ladislav Šenolt
  • Function : Author
Ruben Burgos-Vargas
  • Function : Author
Petra Hanova
  • Function : Author
Ilaria Padovano
  • Function : Author
Tomas Cazenave
  • Function : Author
Maria S Stoenoiu
  • Function : Author
Marina Backhaus
  • Function : Author
Gaël Mouterde
  • Function : Author
Weibin Bao
  • Function : Author
Punit Goyanka
  • Function : Author
Maarten Boers
  • Function : Author
Georg Schett
  • Function : Author
Fichier principal
Vignette du fichier
1-s2.0-S0049017223001014-main.pdf (4.22 Mo) Télécharger le fichier
Origin : Publisher files allowed on an open archive

Dates and versions

hal-04551318 , version 1 (18-04-2024)

Identifiers

Cite

Maria-Antonietta d'Agostino, Philippe Carron, Corine Gaillez, Philip G Conaghan, Esperanza Naredo, et al.. Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extension. Seminars in Arthritis and Rheumatism, 2023, 63, pp.152259. ⟨10.1016/j.semarthrit.2023.152259⟩. ⟨hal-04551318⟩
1 View
1 Download

Altmetric

Share

Gmail Facebook X LinkedIn More